ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

Cancer Survival Now May Be Well Over 50 Percent, ACS President Says; Cigarette Consumption Drops

April 6, 1984

ASCO Expanding Tools To Improve Coordination Of Cancer Treatment

November 30, 2007

Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists

April 12, 2013

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

March 8, 1985